Forskning
Ny forskning 24 juli 2026
Ny forskning 24 juli 2026
Varje dag samlar vi de senast publicerade vetenskapliga studierna om hampa, CBD och cannabis och sammanfattar kort vad var och en undersökte — på svenska och engelska. Alla länkar går till primärkällan (PubMed, Europe PMC eller ClinicalTrials.gov). Sammanfattningarna är neutrala beskrivningar av vad forskarna studerade, inte hälsopåståenden.
Development and in vivo pharmacokinetic evaluation of a phospholipid complex self-nanoemulsifying drug delivery system (PLC-SNEDDS) for enhanced oral bioavailability of cannabidiol.
Drug Deliv · 2026 Dec 31 · PubMed
Svenska: Cannabidiol (CBD) exhibits poor oral bioavailability (approximately 6%) due to low solubility and excessive first-pass metabolism, limiting its therapeutic potential.
Structure-stability relationships of pure cannabinoids and their cocrystals under forced degradation conditions.
J Cannabis Res · 2026 Jul 21 · PubMed
Svenska: Cannabinoids have attracted increasing scientific interest due to their diverse activities and therapeutic potential. However, cannabinoids suffer from limited physicochemical properties, including low melting point, low aqueous solubility, and stability issues.
Epilepsy of infancy with migrating focal seizures: A scoping review of clinical features, diagnostic testing including genetics, long-term outcomes, mortality, and current and emerging therapeutic strategies.
Epilepsy Behav · 2026 Jul 22 · PubMed
Svenska: Epilepsy of infancy with migrating focal seizures (EIMFS) is among the most severe developmental and epileptic encephalopathies (DEEs), marked by intractable multifocal seizures migrating across both hemispheres, profound developmental arrest, and high early mortality.
Cannabis-Based Medicines for Nociplastic Pain: A Scoping Review of Efficacy, Safety, and Patient Outcomes.
J Pain Palliat Care Pharmacother · 2026 Jul 22 · PubMed
Svenska: Cannabis-based medicines (CBM) are increasingly considered for nociplastic pain (NOCP) despite limited evidence. This scoping review mapped evidence on efficacy, safety, patient-reported outcomes, and pharmacokinetic/pharmacodynamic (PK/PD) considerations for CBM in NOCP.
Why does medicinal cannabis remain so popular? Is it the 'entourage effect'?
Intern Med J · 2026 Jul 22 · PubMed
Svenska: Australian demand for medicinal cannabis remains high despite limited evidence of efficacy.
Unveiling the Origin of Regioselectivity in Iron(III)-Promoted Friedel-Crafts Synthesis of Cannabinoids: Theoretical Studies and Synthetic Applications.
J Org Chem · 2026 Jul 23 · PubMed
Svenska: Phytocannabinoids, particularly cannabidiol (CBD), are important targets in pharmaceutical and industrial development due to their promising biological properties.
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
ClinicalTrials.gov (RECRUITING) · 2026-07-17 · ClinicalTrials.gov
Svenska: The purpose of the study is to assess the PK of bimekizumab following subcutaneous (sc) administration in study participants with moderate to severe hidradenitis suppurativa (HS)
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
ClinicalTrials.gov (NOT_YET_RECRUITING) · 2026-07-17 · ClinicalTrials.gov
Svenska: This study is comprised of a main study, an observational study, and optional survey studies.